Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Randviken Fastigheter AB in connection with the acquisition and acquisition financing of real properties for a total agreed property value of approximately SEK 2.8 billion.
Mandate

Vinge has advised Randviken Fastigheter AB in connection with the acquisition and acquisition financing of real properties for a total agreed property value of approximately SEK 2.8 billion.

January 03, 2022 Real Estate and Construction

Vinge has advised Randviken Fastigheter AB (publ) in connection with the acquisition and acquisition financing of real properties for a total agreed property value of approximately SEK 2.8 billion. The acquisition was financed, inter alia, with bank facilities in an approximate amount of SEK 2.3 billion and was completed in December 2021.

The acquired properties are mainly located in Stockholm, Västerås and Malmö and the primary use is warehouse/light industrial, healthcare, school and office. The acquisition also includes a new construction project for office premises.

A significant part of the total loan amount is acquisition loans and the majority of the acquisition loans are senior loans and a smaller part is a bridge loan with a shorter maturity. The bank financing also includes a capex loan which will partly finance the completion of the new construction project.

Vinge’s team included Niclas Winnberg and Kristoffer Larson (Real Estate), as well as Fabian Ekeblad, Arvid Weimers and Elin Samara (Banking and Finance).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025